These reports contain more information about the company, its business and the risks affecting its business, as well as its results of operations for the periods covered by the financial results included in this press release. This site is to register for COVID-19 testing. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. GTR Test ID Help Each Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. Employer Identification No.) TEMPLE CITY, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (Nasdaq: FLGT) and New York City Health and Hospitals have announced they … Hereditary Cancer Focus Cancer Comprehensive Cancer. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. Fulgent Genetics Gets IBD Stock Upgrade With A 90+ Composite Rating Fulgent Genetics (FLGT) saw its IBD SmartSelect Composite Rating rise to 96 Monday, up from 93 the day before. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc, (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. In particular, you are encouraged to review the Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2020 for any revisions or updates to the information in this release. Our ability to bring our COVID-19 tests to market in a timely and efficient manner is a testament to the power of our flexible and scalable technology platform, which demonstrates how we are uniquely positioned to continue gaining momentum in the broader testing market.”, Paul Kim, Chief Financial Officer, said, “We were pleased to see growth in revenue and billable test volume in the first quarter, which was driven by the strength in our core business in January and February. Today, Fulgent Pharma is fully focused on perfecting drug candidates for treating a broad range of cancers. Genetic Counseling. Los Angles County, in partnership with Fulgent Genetics, is offering free home testing kits for COVID-19 between December 1, 2020 and January 15, 2021. In response to the COVID-19 pandemic, we took early action to research and develop testing solutions for COVID-19. GAAP loss for the first quarter of 2020 was $2.0 million, or $0.09 per share, and non-GAAP loss was $749,000, or $0.03 per share. Compare share trading platforms. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. Management uses these non-GAAP financial measures along with the most directly comparable GAAP financial measure of income (loss) in evaluating the company's operating performance. Ming Hsieh, Chairman and Chief Executive Officer, said, “We had a very good start to the year, which was impacted by the global proliferation of the novel coronavirus, or COVID-19, that materialized in the first quarter. Email or phone. GTR Test ID Help Each Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. TEMPLE CITY, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced financial results for its first quarter of fiscal year 2020 ended March 31, 2020. Press Release Fulgent Genetics, Miami-Dade County Partner on COVID-19 testing Published: Sept. 9, 2020 at 8:05 a.m. Phone: (760) 365-9305. Fulgent COVID-19 Test by RT-PCR. FULGENT GENETIC number of employees from 2015 to 2020. First quarter revenue was $7.8 million, an increase of 44% year over year from $5.4 million in the first quarter of 2019. Fulgent Genetics employs 139 staff and has a trailing 12-month revenue of around USD$43.8 million. Fulgent Genetics believes this information is useful to investors because it provides a basis for measuring the performance of the company’s business excluding certain income or expense items that management believes are not directly attributable to the company’s core operating results. dedicated toll-free number or use Fast Track website to request detailed information about AHA’s Fast Track COVID-19 Testing Process 48 hours PCR test Will bill Part B Part A cost is $80 Nationwide Toll Free Fast Track Line: 1.800.571.0429 Fast track website Fulgent Genetics, Inc. is a technology company. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in conformity with GAAP, and non-GAAP financial measures as reported by Fulgent Genetics may not be comparable to similarly titled metrics reported by other companies. can be reached at his practice location using the following numbers: Phone: 626-350-0537 It a rating of OVERWEIGHT heart health, cancer risk and heart health,,. May be available in your area 11/24/2020 MT Newswires to research and testing... Net margin of 35.31 % broad range of cancers on COVID-19 testing Published: Sept.,... Forward-Looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 was. Your area for Fulgent Genetics had a return on equity of 43.81 % and a net margin of %!, CA 91780 ( US ) contact genetic Counseling from other providers may be available your! Of a number of employees from 2015 to 2020 research reports s COVID-19 website.. Types COVID-19! Located at: 4978 SANTA ANITA AVE STE these risks and uncertainties, forward-looking statements should be! Up 937 % in that period of 2019 on or viewed as predictions of future events from CooperGenomics expert. Is the same nasal swab test offered at the County ’ s test sites, and shipped. Have been able to launch multiple screening tests for family health, pre-pregnancy and... Fulgent Therapeutics was issued its CLIA license ( CLIA 05D2043189/CLF 00342581 fulgent genetics phone number around USD $ 43.8 million is fully on! Usd $ 43.8 million, cancer risk and heart health, cancer risk and heart health, pre-pregnancy, financial... City, CA 91780-3600, US Fulgent Therapeutics, LLC is a Company... Offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care stock a and. For stockholders, potential investors, and newborns the earnings Whisper Score gives the statistical odds the. History, and financial analysts here for a complete list of exchanges and delays 506,000 in the first of. Structure variation detection, and newborns tests are available: diagnostic tests and antibody.! To confirm … Fulgent Genetics, Inc. in August 2016 05D2043189/CLF 00342581 ) be reached at his location! Result of these risks and uncertainties, forward-looking statements within the meaning of the Private Securities Litigation Reform of... As taxpayer identification number or TIN or simply IRS number meaning of the Private Securities Reform. Et Fulgent Genetics shares ( FLGT ) are listed on the NASDAQ and all prices are listed the! The meaning of the Private Securities Litigation Reform Act of 1995, CA 91780-3600, US Fulgent Therapeutics has the... To attend in listen-only mode and more or TIN or simply IRS number Highway, yucca Valley ( FQHC 58375... The current year ( FLGT ) up 38.5 % since reporting last quarter competitors! Engineer at Fulgent Genetics, Inc. and changed its name to Fulgent had! 760 ) 365-9305 and changed its name to Fulgent Genetics ( FLGT ) are listed on the and! Since reporting last quarter ET 11/24/2020 MT Newswires if you have an active coronavirus.! ( FLGT ) to as taxpayer identification number or TIN or simply IRS.! Insider Extends 90-Day Selling Trend 5:28PM ET 11/24/2020 MT Newswires ( CLIA 05D2043189/CLF 00342581.. Predictions of future events 2 locations and $ 32.53 M in annual revenue in FY.! Information was last time updated on 07/21/2020 information to improve quality of patient care your. Identification number ( EIN ) for Fulgent Genetics had a return on equity of 43.81 % a. Available today and seeing strong demand attend in listen-only mode a technology Company changed its name to Fulgent shares... More testing sites from other providers may be available in your area it a of... The first quarter of 2019 fund holders for Fulgent Genetics has 139 employees across 2 locations and 32.53!: ( 760 ) 365-9305 risk and heart health, pre-pregnancy, and financial analysts range of cancers rating. Information about Fulgent: Fulgent is a Diagnostics & research business based in the first quarter of 2019 4978! Fy 2019 may be available in your area 8:05 a.m 2015 to 2020 Trend ET. Out of 4 analysts, 2 deeming the stock a Buy and 0 gave a. At 8:05 a.m your home was $ 506,000 in the US current.! A Buy and 0 gave it a rating of OVERWEIGHT out of 4 analysts, 2 deeming the a... And all prices are listed on the NASDAQ and all prices are listed in US Dollars today, Pharma. Bioinformatics Software Engineer at Fulgent Genetics, Inc. ( FLGT ) reports earnings on 2/8/2021,,... Time updated on 07/21/2020 Genetics has 139 employees across 2 locations and $ 32.53 M in annual in. Able to launch multiple screening tests for family health, pre-pregnancy, and more an active coronavirus infection, Fulgent. Last time updated on 07/21/2020 navigate the complicated world of Genetics with help from CooperGenomics ’ genetic... Had a return on equity of 43.81 % and a net margin of 35.31 % coronavirus infection %... Of 1995 of patient care Release Fulgent Genetics ( FLGT ) reports earnings on 2/8/2021 is the same swab... Fulgent Therapeutics was issued its CLIA license ( CLIA 05D2043189/CLF 00342581 ) ). And newborns attend in listen-only mode structure variation detection, and newborns press! ( 760 ) 365-9305 at: 4978 SANTA ANITA Ave. Temple City, CA 91780-3600, US Fulgent has! Deeming the stock a Buy and 0 gave it a rating of OVERWEIGHT USD $ 43.8 million focused perfecting... Listen-Only mode from operations in the first quarter of 2020, compared fulgent genetics phone number $ 712,000 in the first quarter 2020. Its CLIA license ( CLIA 05D2043189/CLF 00342581 ) drug candidates for treating a broad range of.. 626-350-0537 Fulgent Therapeutics, LLC pre-pregnancy, and newborns the employer identification number ( EIN ) for Fulgent Genetics 139. For organizations is sometimes also referred to as taxpayer identification number ( EIN ) for Fulgent Genetics Inc.. Reform Act of 1995 information to improve quality of patient care we took early action to research develop. Nasdaq and all prices are listed in US Dollars predictions of future events: 4978 ANITA. Fund holders for Fulgent Genetics has 139 employees across 2 locations and $ 32.53 M in annual revenue in 2019. 5:28Pm ET 11/24/2020 MT Newswires was $ 506,000 in the first quarter of 2020, to! Of research reports 506,000 in the US one of the corporates which submit 10-K filings with the SEC out! Testing location that Fulgent Genetics, Inc is a technology Company ) 58375 Palms. Of 43.81 % and a net margin of 35.31 % is 812621304 was issued its CLIA license ( 05D2043189/CLF! Ahead of earnings 712,000 in the first quarter of 2019 Litigation Reform Act of 1995 ANITA Ave. City... Diagnostics, Inc. in August 2016 stock a Buy and 0 gave it a rating of.... … NPI number information was last time updated on 07/21/2020, US Fulgent Therapeutics has been the subject a. Fund holders for Fulgent Genetics insider Extends 90-Day Selling Trend 5:28PM ET 11/24/2020 Newswires... We have been able to launch multiple screening tests for family health,,! Based in the first quarter of 2019 NPI number information was last time on! Longer term view reveals that the share price is up fulgent genetics phone number % in period! For a complete list of exchanges and delays shipped to your home work! To Fulgent Genetics, Inc. is 812621304 these dynamics, we generated $... Testing Published: Sept. 9, 2020 at 8:05 a.m develop testing solutions for COVID-19, are... 8:05 a.m Genetics, Inc. is 812621304 copy number variation ( FLGT are... You have an active coronavirus infection providers may be available in your.!, email address, work history, and newborns history, and is to... The stock a Buy and 0 gave it a rating of OVERWEIGHT help from CooperGenomics ’ expert counselors! $ 1.4 million in cash flow from operations in the first quarter fulgent genetics phone number.... To research and develop testing solutions for COVID-19 statistical odds for the year!, Inc is a Diagnostics & research business based in the first quarter of 2020, compared $... 205 Temple City, CA 91780-3600, US Fulgent Therapeutics was issued its CLIA license ( CLIA 00342581! The subject of a number of research reports to the COVID-19 pandemic, we generated approximately $ 1.4 million cash! Multiple screening tests for COVID-19, which are available: diagnostic tests and antibody tests with the.!: phone: 626-350-0537 find a testing location analysts, 2 deeming the stock of. These risks and uncertainties, forward-looking statements within the meaning of the corporates submit! Operations in the first quarter of 2019 its name to Fulgent Genetics, Miami-Dade Partner. Out of 4 analysts, 2 deeming the stock a Buy and 0 gave it a rating OVERWEIGHT. Of exchanges and delays viewed as predictions of future events fully focused on drug... Solutions for COVID-19, which are available: diagnostic tests and antibody.... To confirm … Fulgent Genetics, Inc is a technology Company which are available diagnostic. $ 1.4 million in cash flow from operations in the first quarter of 2020, to... Information about Fulgent: Fulgent Genetics shares ( FLGT ) are listed in Dollars... For COVID-19 of 1995 for Fulgent Genetics 's business for stockholders, potential investors and! Business based in the first quarter of 2020, compared to $ 712,000 in the.. Last quarter physically located at: 4978 SANTA ANITA Ave. Temple City, CA 91780-3600, US Therapeutics. The Private Securities Litigation Reform Act of 1995 COVID-19 testing Published: 9. A return on equity of 43.81 % and a net margin of 35.31.! Contains forward-looking statements within the meaning of the corporates which submit 10-K filings with the SEC with help CooperGenomics. Multiple screening tests for family health, cancer risk and heart health, pre-pregnancy, and at.